HP568

· Hinova Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HP568, covering 2025-01-03 to 2025-01-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast Cancer [Phase 1, Phase 2]

See pricing